Helus Pharma
1 known investors
Find your way into Helus Pharma
1,079 people in our graph share verified history with the Helus Pharma team — schools, employers, funds. One of them is your warm intro.
Adam Valkinunlockedknows Alex Nivorozhkin · together at Harvard University (overlapped)
×4knows the team · via GlaxoSmithKline
knows the team · via McGill University
×3knows the team · via Harvard University
knows the team · via Villanova University Charles Widger School of Law
knows the team · via Davis Polk & Wardwell LLP
Helus Pharma is a clinical-stage biopharmaceutical company developing small-molecule therapies for psychiatric and CNS conditions such as depression, anxiety, schizophrenia, and bipolar disorder. It focuses on advancing novel treatments for mental health disorders through clinical development and commercialization.
Founders & leadership
ES
Eric SoinCo-Founder, Executive ChairmanEric So is co-founder and executive chairman of Helus Pharma, a clinical-stage biopharmaceutical company developing small-molecule therapies for psychiatric and CNS conditions. He has held C-level roles in corporate strategy, development, and finance across public and private companies at various stages of growth.
JK
John KanakisinCo-FounderJohn Kanakis is co-founder of Helus Pharma, a clinical-stage biopharmaceutical company developing small-molecule therapies for psychiatric and neurological conditions. He brings approximately 25 years of experience across private and public companies, with a track record of founding multiple ventures in biotech, medtech, cleantech, AI, and cybersecurity sectors.
PG
Paul GlavineinCo-Founder and Chief Growth OfficerPaul Glavine is Co-Founder and Chief Growth Officer at Helus Pharma, a clinical-stage biopharmaceutical company developing small-molecule therapies for psychiatric and CNS conditions. He also serves as Chairman of the Board at LongPoint ETFs, a firm focused on Canadian ETF strategies.
MH
Michael HalsteadinChief Executive OfficerMichael Halstead is Chief Executive Officer of Helus Pharma, a clinical-stage biopharmaceutical company developing small-molecule therapies targeting psychiatric and CNS conditions including depression and anxiety.
MC
Michael ColaChief Executive Officer
AB
Aaron BartloneinChief Operating OfficerAaron Bartlone is Chief Operating Officer of Helus Pharma, a clinical-stage biopharmaceutical company developing small-molecule therapies for psychiatric and CNS disorders. He has extensive experience in product development, clinical trials, regulatory affairs, and commercialization across the biopharmaceutical industry, with involvement in nine new drug commercializations.
LC
Lori ChallengerinChief Compliance, Ethics & Administrative OfficerLori Challenger is Chief Compliance, Ethics & Administrative Officer at Helus Pharma, a clinical-stage biopharmaceutical company developing small-molecule therapies for psychiatric and CNS conditions. She brings over 20 years of experience in compliance, governance, organizational transformation, and people operations across startups, scale-ups, and publicly traded companies in regulated industries.
AI
Amir InamdarinChief Medical OfficerAmir Inamdar is a psychiatrist with over 20 years of experience in clinical research and drug development for psychiatric disorders. He has led clinical trial design and regulatory strategy for novel psychiatric therapeutics, including first-in-human, proof-of-concept, and pivotal studies.
AN
Alex NivorozhkininChief Scientific OfficerAlex Nivorozhkin is Chief Scientific Officer of Helus Pharma, a clinical-stage biopharmaceutical company developing small-molecule therapies for psychiatric and CNS disorders. He has held senior executive roles and contributed inventions in life sciences and pharmaceuticals.
GC
Greg CaversChief Financial Officer
GF
Gabe FahelChief Legal Officer
GT
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountstock offeringJul 2026Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through Helus Pharma went on to found or lead other companies.
In the news
Helus Pharma Appoints Michael Halstead CEO, Completes Enrollment in Phase 3 APPROACH Study of HLP003 and Reports Q2 2026 Results | Quiver Quantitativequiverquant.com · Aug 2026Frequently asked questions
- What does Helus Pharma do?
- Helus Pharma is a clinical-stage biopharmaceutical company developing small-molecule therapies for psychiatric and CNS conditions such as depression, anxiety, schizophrenia, and bipolar disorder. It focuses on advancing novel treatments for mental health disorders through clinical development and commercialization.
- Who founded Helus Pharma?
- Helus Pharma was founded by Eric So, John Kanakis, Paul Glavine.
- Who are Helus Pharma's investors?
- Helus Pharma's investors include O2h Ventures.